District of Columbia v. Basiliko, DC, No. 91-2528 (Judge Joyce Hens Green), 9/16/94.

Settlement with and judgments against real estate speculators who rigged bids at public land auctions.

Read More →

District of Columbia v. Marquee Holdings Inc. and LCE Holdings, Inc.

District of Columbia filed a complaint and a proposed stipulated final judgment simultaneously. The complaint alleged that the merger of movie chains AMC and Loews would substantially lessen competition in the District of Columbia. The stipulated final judgment requires the divestiture of one AMC theatre and one Loews theater, and prohibits the defendants from entering into contracts restricting the rights of theater landlords to rent former AMC and Loews theaters to new theater tenants.

Read More →

New York v. Microsoft Corp., 97 F. Supp. 2d 59 (D.D.C. 2000)

U.S. Department of Justice and the Plaintiff States alleged that the Defendant, Microsoft Corporation violated State and Federal law by maintaining a monopoly in the market for Intel-compatible personal computer operating systems and by illegally tying its Windows operating system to its Internet Explorer browser.

Read More →

U.S. v. First Data Corporation and Concord EFS, Inc., 1:03CV02169 (D.D.C. filed 10/23/03)

The U.S. Department of Justice (DOJ) and Plaintiff States sought to enjoin the merger between First Data Corporation (First Data) and Concord EFS, Inc. (Concord), alleging that the merger would substantially lessen competition in the financial services market.

Read More →

In re Mid-Atlantic Toyota Antitrust Litigation, 560 F. Supp. 760 (D. Md. 1983); 605 F. Supp 440 (D. Md 1984)

Plaintiff States sought damages, alleging defendant distributors and dealers conspired to set the prices for which Toyota automobiles were sold among various dealerships.

Read More →

Texas v. Zeneca, 1997 U.S. Dist. LEXIS 13153 (N.D. Tex. 1997)

States sought an injunction and monetary damages from Zeneca, Inc. (Zeneca), alleging that the company conspired with distributors of its crop protection chemicals to maintain the resale price of the chemicals.

Read More →

In re Clozapine Antitrust Litigation, MDL No. 874 (N.D. Ill. 1991)

Plaintiff States sought monetary damages and injunctive relief against Sandoz Pharmaceuticals Corporation (Sandoz), alleging the company unlawfully required those who purchased its drug, Clozapine, to also purchase distribution and patient monitoring services from Sandoz.

Read More →

New Jersey v. Exxon Corp. No. 1:99CV03183 (D.D.C. Nov. 30, 1999); Alaska v. Exxon Corp. No. A99-618-CV (D. Alaska, Nov. 30, 1999); Texas v. Exxon Corp. No. 3-99CV 2709-L (N.D. Texas, Dallas, Dec. 3, 1999); California v. Exxon

Plaintiff States sought to enjoin the merger between Exxon Corporation (Exxon) and Mobil Corporation (Mobil), alleging that the merger would violate Section 7 of the Clayton Act because the acquisition would substantially lessen competition and/or tend to lessen competition in relevant markets in each of the States.

Read More →

In re: Buspirone Antitrust Litigation,Case No. 01 CV 11401, MDL 1410, MDL 1413 (S .D.N.Y.) (see also Ohio v. Bristol Myers Squibb

Plaintiff States sought damages and injunctive relief, alleging that Bristol-Myers Squibb Co. (BMS) attempted to maintain an unlawful monopoly on buspirone hydrochloride, a medication used to treat generalized anxiety. In settling, BMS agreed to a stipulated injunction and to reimburse consumers and state and local public entities for overcharges. In 2008, plaintiff states sued BMS for failing to report accurately to the states, pursuant to the settlement, a patent arrangement involving the drug Plavix. The company pleaded guilty to lying to the FTC and the states recovered $1.1 million in fines.

Read More →

In re Disposable Contact Lens Antitrust Litigation, 2001-1 Trade Cas. (CCH) & 73,150

Plaintiff States sought damages and injunctive relief against the three major contact lens makers and the American Optometric Association. The States alleged that defendants conspired to cut mail order companies and pharmacies out of the market for replacement contact lenses.

Read More →